Artemis DNA Wins 2022 Association for Corporate Growth Award

Artemis DNA Wins 2022 Association for Corporate Growth Award

Artemis DNA, Inc. (“Artemis DNA” or the “company”), the US-based leading genetics company, proudly announced today that they have been selected as the winner of the Association of Corporate Growth (ACG) Orange County’s Annual Award for Startups.  The honor by ACG is the latest in a number of recognitions for Artemis DNA including being recently named as a Top Workplace and having multiple employees win or be nominated for prestigious industry awards.

The 27th Annual ACG Orange County Awards were held May 12, and celebrate the best middle-market firms in Orange County and the Inland Empire, as chosen by a panel of respected independent judges.  The gala was emceed by none other than CNBC’s Jane Wells, an award-winning broadcast journalist with over 30 years of experience in the news media.

“It was so exciting to be selected by ACG for this distinguished award,” commented Ms. Emylee Thai, Founder and CEO of Artemis DNA. “The work we are doing at Artemis DNA has the potential to truly change lives for people all around the world.  I am honoured to accept this recognition on behalf of the entire Artemis DNA team that works so hard to meet our lofty goals while revolutionizing the healthcare industry.”

Ms. Thai has over a decade of experience in the healthcare industry having worked in various capacities for several top-tier firms including serving as the General Partner for Orion Modern, an innovative healthcare focused venture capital firm.  A serial entrepreneur with a proven history of success, Ms. Thai was motivated to start Artemis DNA by a passion to make innovative, affordable and actionable healthcare solutions accessible to all.  Artemis DNA is currently operating in both the United States and Vietnam, has plans to continue to expand globally.

About Artemis DNA

Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics.

Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices.  Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services. Artemis DNA is headquartered in Irvine, California. For more information, visit https://www.artemisdna.com.